Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve To consider and approve the Un-Audited Financial Results of the Company for the Quarter ended on 31st December, 2025.This is also to inform that the Trading Window of the Company has been closed from 01st January, 2026 and will remain closed till the completion of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended on 31st December, 2025.2. Any other agenda, with prior permission of Chairperson.
Johnson Pharmacare Limited Press Release Feb 05 2026
Filed with BSE · · 2 pages · English
Release
Johnson Pharmacare Limited on 6ix
Earlier from Johnson Pharmacare
- Johnson Pharmacare Limited Press Release Feb 02 2026
- Johnson Pharmacare Limited Press Release Jan 31 2026
- Johnson Pharmacare Limited Press Release Jan 24 2026
- Johnson Pharmacare Limited Press Release Jan 13 2026
- Johnson Pharmacare Limited Press Release Jan 08 2026
Later from Johnson Pharmacare
- Johnson Pharmacare Limited Press Release Feb 09 2026
- Johnson Pharmacare Limited Press Release Feb 12 2026
- Johnson Pharmacare Limited Press Release Feb 13 2026
- Johnson Pharmacare Limited Press Release Feb 16 2026
- Johnson Pharmacare Limited Press Release Mar 21 2026
Follow Johnson Pharmacare into a list and get an email when it puts out news.
Follow Johnson Pharmacare